Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.
2.

Methods for gene transfer to the central nervous system.

Kantor B, Bailey RM, Wimberly K, Kalburgi SN, Gray SJ.

Adv Genet. 2014;87:125-97. doi: 10.1016/B978-0-12-800149-3.00003-2. Review.

3.

Invasive drug delivery.

Blömer U, Ganser A, Scherr M.

Adv Exp Med Biol. 2002;513:431-51. Review.

PMID:
12575831
4.

Adeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system.

Blessing D, Déglon N.

Curr Opin Virol. 2016 Dec;21:61-66. doi: 10.1016/j.coviro.2016.08.004. Epub 2016 Aug 23. Review.

PMID:
27559630
5.

Biosafety features of lentiviral vectors.

Schambach A, Zychlinski D, Ehrnstroem B, Baum C.

Hum Gene Ther. 2013 Feb;24(2):132-42. doi: 10.1089/hum.2012.229. Review.

6.

Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Dreyer JL.

Mol Biotechnol. 2011 Feb;47(2):169-87. doi: 10.1007/s12033-010-9334-x. Review.

PMID:
20862616
7.

Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells.

Zhang Y, Liu Y, Zhu G, Qiu Y, Peng B, Yin J, Liu W, He X.

J Neurovirol. 2010 Nov;16(6):419-26. doi: 10.3109/13550284.2010.520818. Epub 2010 Oct 25. Review.

PMID:
20969536
8.

Lentiviral vector-mediated RNA silencing in the central nervous system.

Hutson TH, Foster E, Moon LD, Yáñez-Muñoz RJ.

Hum Gene Ther Methods. 2014 Feb;25(1):14-32. doi: 10.1089/hgtb.2013.016. Epub 2013 Nov 1. Review.

9.

Gene delivery with viral vectors for cerebrovascular diseases.

Gan Y, Jing Z, Stetler RA, Cao G.

Front Biosci (Elite Ed). 2013 Jan 1;5:188-203. Review.

10.

Transduction of brain by herpes simplex virus vectors.

Berges BK, Wolfe JH, Fraser NW.

Mol Ther. 2007 Jan;15(1):20-9. Review.

11.

Integration-deficient lentiviral vectors: a slow coming of age.

Wanisch K, Yáñez-Muñoz RJ.

Mol Ther. 2009 Aug;17(8):1316-32. doi: 10.1038/mt.2009.122. Epub 2009 Jun 2. Review.

12.

In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles.

Dissen GA, Lomniczi A, Neff TL, Hobbs TR, Kohama SG, Kroenke CD, Galimi F, Ojeda SR.

Methods. 2009 Sep;49(1):70-7. doi: 10.1016/j.ymeth.2009.06.004. Epub 2009 Jun 24. Review.

13.
14.

Production and titration of lentiviral vectors.

Salmon P, Trono D.

Curr Protoc Neurosci. 2006 Nov;Chapter 4:Unit 4.21. doi: 10.1002/0471142301.ns0421s37. Review.

PMID:
18428637
15.

Barriers to non-viral vector-mediated gene delivery in the nervous system.

Pérez-Martínez FC, Guerra J, Posadas I, Ceña V.

Pharm Res. 2011 Aug;28(8):1843-58. doi: 10.1007/s11095-010-0364-7. Epub 2011 Jan 12. Review.

16.

Clinical applications involving CNS gene transfer.

Kantor B, McCown T, Leone P, Gray SJ.

Adv Genet. 2014;87:71-124. doi: 10.1016/B978-0-12-800149-3.00002-0. Review.

17.

Hydrogels for lentiviral gene delivery.

Seidlits SK, Gower RM, Shepard JA, Shea LD.

Expert Opin Drug Deliv. 2013 Apr;10(4):499-509. doi: 10.1517/17425247.2013.764864. Epub 2013 Jan 25. Review.

18.

Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Sizemore RJ, Seeger-Armbruster S, Hughes SM, Parr-Brownlie LC.

J Neurophysiol. 2016 Apr;115(4):2124-46. doi: 10.1152/jn.01131.2015. Epub 2016 Feb 17. Review.

19.

A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies.

White M, Whittaker R, Gándara C, Stoll EA.

Hum Gene Ther Methods. 2017 Aug;28(4):163-176. doi: 10.1089/hgtb.2017.096. Review.

20.

Lentivirus-Based Genetic Manipulations in Neurons In Vivo.

Osten P, Dittgen T, Licznerski P.

In: Kittler JT, Moss SJ, editors. The Dynamic Synapse: Molecular Methods in Ionotropic Receptor Biology. Boca Raton (FL): CRC Press/Taylor & Francis; 2006. Chapter 13.

Supplemental Content

Support Center